Taken together, our results showed that at least COL1A1, ACTA2, and FAP were significantly upregulated on mRNA levels in CAS from canine mammary carcinoma similar to human mammary carcinoma samples, whereas CXCL12 is downregulated. This evidence concerns the gene COL1A1 and breast carcinoma.